# Effect of Salidroside on Pregnancy Outcomes in High Childbearing Age Patients in Viro Fertilization

> **NCT06990685** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The Second Hospital of Shandong University** · enrollment: 370 (estimated)

## Conditions studied

- Salidroside
- Randomized Controlled Trial
- In Vitro Fertilization
- Assisted Reproductive Technology

## Interventions

- **DRUG:** Salidroside

## Key facts

- **NCT ID:** NCT06990685
- **Lead sponsor:** The Second Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-12
- **Target enrollment:** 370 (ESTIMATED)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06990685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06990685, "Effect of Salidroside on Pregnancy Outcomes in High Childbearing Age Patients in Viro Fertilization". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06990685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
